Vallum received FDA 510(k) clearance to market a PEEK interbody fusion device with a PEEKplus® nanotextured surface created with proprietary Accelerated Neutral Atom Beam technology.
Five-year follow-up results demonstrate that Cartiva's Synthetic Cartilage Implant provided long-term durability in pain and functional improvements in the treatment of great toe arthritis.
Artoss completed a US $1MM funding round. Proceeds will support development of new NanoBone® bone graft products for the U.S. market, regulatory requirements and commercialization.